Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor - sprookjes - yvandenbroek - TriplyDB

Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor

Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor

http://www.wikidata.org/entity/Q28571602

about

Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor Cytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaques Mammalian soluble epoxide hydrolase is identical to liver hepoxilin hydrolase Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice Possible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disorders Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor Red blood cells (RBCs), epoxyeicosatrienoic acids (EETs) and adenosine triphosphate (ATP)Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation Bioactive lipid profiling reveals drug target engagement of a soluble epoxide hydrolase inhibitor in a murine model of tobacco smoke exposure The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation Epoxides and soluble epoxide hydrolase in cardiovascular physiology Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain Soluble epoxide hydrolase is a therapeutic target for acute inflammation Macrophage epoxygenase determines a profibrotic transcriptome signature.The cloning and characterization of a soluble epoxide hydrolase in chicken.Development of a high-throughput screen for soluble epoxide hydrolase inhibition EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides.11,12-Epoxyeicosatrienoic acid induces vasodilator response in the rat perfused mesenteric vasculature.Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.8,9-Epoxyeicosatrienoic acid inhibits antibody production of B lymphocytes in mice The role of epoxide hydrolases in health and disease.Genetic polymorphisms in arginase I and II and childhood asthma and atopy Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma The anti-inflammatory effects of soluble epoxide hydrolase inhibitors are independent of leukocyte recruitment.Soluble epoxide hydrolase inhibitor attenuates inflammation and airway hyperresponsiveness in mice.2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion Prevention of hypertension in DOCA-salt rats by an inhibitor of soluble epoxide hydrolase.Dihydroxyoctadecamonoenoate esters inhibit the neutrophil respiratory burst.Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease.Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols.Reduction of inflammatory bowel disease-induced tumor development in IL-10 knockout mice with soluble epoxide hydrolase gene deficiency.

P2860

686bb6545ae2d11663a04bd62292dd5b6bdba8d3

P248

Q23910189-A4F5F054-BC1A-4ADD-B8B6-9EA518552DD7 Q24597172-CBD68657-341F-4649-88F5-3975D5E75EEB Q24618018-C000C83C-7B01-4604-BC87-E53773E7560C Q28270421-B93507AF-E696-46D5-AE01-7AD00DA3EE12 Q28281019-BB59A4EA-A320-4E4D-B6A6-7D90BF25589F Q28302779-F092E9EB-F563-4644-ABEE-52C1210BDA12 Q28304230-E9B5059E-90EF-4079-B6A5-9B8FF40681BE Q28385015-BC202A32-91F9-4BEE-9F83-B0449EC51AE4 Q28385835-5DC45ABD-BF34-4C00-9774-70EADF2FAEDA Q28386662-75C1F334-66B4-457A-8A54-052E27C1E2F2 Q28387686-157D39C4-F386-4C94-A705-2EF2DEC00EB3 Q28388012-5D5ED7EF-8A3D-4BBE-B0A1-F831D19A593F Q28389323-4EFBEB84-1535-4289-8E1A-BD7A52A3A88C Q28391533-E26F2954-B07B-448F-A456-DAA815D18B9E Q28391885-0B37EEF8-9F40-45C7-B7D2-1BD59A8D9082 Q28392416-477BE873-7456-4AA3-9405-8E18491E2420 Q28393303-11692D0C-5364-4D35-8E13-12F4C4B4A2C5 Q28396313-9D758BA4-E908-4C75-87CB-3F454A671502 Q28396881-22495F4C-C4FA-4DD1-A318-6F213049A43A Q28396888-645EF4CC-582F-453B-81FF-37C01302E650 Q28564290-9F166E94-67F2-4017-B7FE-B24C10D6AB66 Q29620593-E094B908-4E54-41A3-BB42-B98D73310FAD Q30273952-67528717-5C6A-49D6-AB96-E57DAB4F8FDB Q30445450-6EB5C510-5C70-496E-9B38-F46ABF22FD18 Q30816822-8EBE0612-313E-4DC7-A7C9-0D2F150DDA66 Q33288850-E8751F12-F249-4EE9-B00D-B5A22B3E4934 Q33578326-E39FC126-95F7-4D36-8440-E7C19F9007B7 Q33814824-3B03C49B-31B5-4770-AE06-AEBA08715CE3 Q34339690-E507D73D-D9E6-4625-A15E-508ACE3C0EE7 Q34440084-8AED214C-63FD-488E-BC89-AD76A231F3FE Q34574103-10AB878B-9E36-4FBB-AF7E-DC0592D444E9 Q34986906-3EB2373E-D12E-46BE-97A0-2F1A30E130E6 Q35196023-CD6BBCB0-30EE-4D03-892F-89AD70EB2E08 Q35207683-AB1860A6-A0FF-463D-84A6-AA860D0CD4E0 Q35783207-6D3779A9-8587-42D3-8D2C-5CB963E60B57 Q35842836-743D73DA-58DA-481E-AF8C-981932E1818F Q35865405-CA2B5618-B9E4-4760-A11F-4055D59F6913 Q35987189-918A6B01-ABA4-423E-879A-E2587BB461BD Q36056415-7B3751C0-6D9D-4659-83F2-DA1E4F327C16 Q36124088-2C549244-6BC0-46C8-A6E5-2072E5D6F598

P2860

Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor

http://www.wikidata.org/entity/Q28571602

description

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

article publié dans les Procee ...... f the United States of America

@fr

artículu científicu espublizáu en 2005

@ast

im Februar 2005 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2005/02/08)

@sk

vědecký článek publikovaný v roce 2005

@cs

wetenschappelijk artikel (gepubliceerd op 2005/02/08)

@nl

наукова стаття, опублікована в лютому 2005

@uk

name

Attenuation of tobacco smoke-i ...... le epoxide hydrolase inhibitor

@ast

Attenuation of tobacco smoke-i ...... le epoxide hydrolase inhibitor

@en

Attenuation of tobacco smoke-i ...... le epoxide hydrolase inhibitor

@nl

type

label

Attenuation of tobacco smoke-i ...... le epoxide hydrolase inhibitor

@ast

Attenuation of tobacco smoke-i ...... le epoxide hydrolase inhibitor

@en

Attenuation of tobacco smoke-i ...... le epoxide hydrolase inhibitor

@nl

prefLabel

Attenuation of tobacco smoke-i ...... le epoxide hydrolase inhibitor

@ast

Attenuation of tobacco smoke-i ...... le epoxide hydrolase inhibitor

@en

Attenuation of tobacco smoke-i ...... le epoxide hydrolase inhibitor

@nl

P1433

Q28571602-A31589A6-B393-4759-AB2B-E96C8458EB79

P1476

Q28571602-83458BC3-0DE8-4B9D-A55D-C570D7EB78F9

P2093

Q28571602-4F77ED82-6F75-4925-9923-125C2B41D787

Q28571602-7C2C29B4-201B-4A39-8728-9F5B6373FBB3

Q28571602-B8EF2E88-5906-4D33-A5AF-270B9CC6ED03

Q28571602-DCC7660C-E194-40E4-8C76-5EE57A764322

Q28571602-F5313A90-14D9-4110-849C-E5C21DBBA723

Q28571602-FF8C6F80-A0E9-4CD6-9754-0220F71D7372

P2860

Q28571602-07A50179-D822-41BF-B574-FC506F28B8C4

Q28571602-0E9409F1-B1CB-4438-BBEB-51C5C1B01663

Q28571602-13980198-4CD3-42DE-AD8B-E533BA91AB6C

Q28571602-31CCF99D-7A3B-46AF-BF9C-31005BD839B1

Q28571602-352C6249-34AB-439E-B977-D20F7FE1EBA6

Q28571602-3897CB67-2F44-4433-989B-6191F1789790

Q28571602-3CA7D7A2-DF54-44A9-9B85-4E97B72AB284

Q28571602-44D14EA2-AB14-4E04-8A00-E47918EA83D5

Q28571602-5ED9E2CA-FEA8-44E6-98E3-999C9B1A8663

Q28571602-7C1CD629-B7E6-45DD-85D9-2EF38AF406F0

P304

Q28571602-A90CB649-EC21-427A-AFFB-5ED220165A47

P31

Q28571602-544C644E-8FFE-43D7-B3CB-91D9026F61EA

P3181

Q28571602-4F0256E4-8005-483F-B8B8-184B0515D90E

P356

Q28571602-9A95663D-53C8-4E4B-B0E3-2C7E5853C3C0

P407

Q28571602-40441E12-4B62-4BD8-B117-73A0ACD0A37E

P433

Q28571602-4DA1D019-2191-4433-B4F0-809C93B4BAD9

P478

Q28571602-EAB91348-89E4-4ED5-B062-F504E2C49EFB

P577

Q28571602-B8FBB707-101D-4975-B409-80D3B851AB88

P5875

Q28571602-8F05552B-05AA-4674-88F6-3501756D6B32

P698

Q28571602-5C06B40A-7F94-4E38-92BE-04E4481A8DCF

P921

Q28571602-F8B2C1A0-C062-400E-8625-62B0DCA65E2B

P932

Q28571602-875DBE95-4F0C-4DE0-8262-5203F87FC287

P3181

P356

PNAS.0409591102

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Attenuation of tobacco smoke-i ...... le epoxide hydrolase inhibitor

@en

P2093

Bruce D. Hammock

http://www.w3.org/2001/XMLSchema#string

Kent E. Pinkerton

http://www.w3.org/2001/XMLSchema#string

Kevin R. Smith

http://www.w3.org/2001/XMLSchema#string

Seung Jin Ma

http://www.w3.org/2001/XMLSchema#string

Takaho Watanabe

http://www.w3.org/2001/XMLSchema#string

Theresa L. Pedersen

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

New role for epoxyeicosatrienoic acids as anti-inflammatory mediators

Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation

The role of methyl-linoleic acid epoxide and diol metabolites in the amplified toxicity of linoleic acid and polychlorinated biphenyls to vascular endothelial cells.

Leukotoxin-diol: a putative toxic mediator involved in acute respiratory distress syndrome.

Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds.

Structural and inflammatory changes in COPD: a comparison with asthma.

Potent urea and carbamate inhibitors of soluble epoxide hydrolases.

Is there a role for systemic corticosteroids in the management of stable chronic obstructive pulmonary disease?

Chronic obstructive pulmonary disease: role of bronchiolar mast cells and macrophages.

P304

2186–2191

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3443026

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0409591102

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8048419

http://www.w3.org/2001/XMLSchema#string

P698

15684051

http://www.w3.org/2001/XMLSchema#string

P921

P932

548576

http://www.w3.org/2001/XMLSchema#string